These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12142645)

  • 1. Pharmacokinetic interaction between high-dose methotrexate and oxacillin.
    Titier K; Lagrange F; Péhourcq F; Moore N; Molimard M
    Ther Drug Monit; 2002 Aug; 24(4):570-2. PubMed ID: 12142645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.
    Vilay AM; Mueller BA; Haines H; Alten JA; Askenazi DJ
    Pharmacotherapy; 2010 Jan; 30(1):111. PubMed ID: 20030480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
    Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
    Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?
    Chan BS; Dawson AH; Buckley NA
    Clin Toxicol (Phila); 2017 Feb; 55(2):88-96. PubMed ID: 28084171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.
    Santucci R; Levêque D; Kemmel V; Lutz P; Gérout AC; N'guyen A; Lescoute A; Schneider F; Bergerat JP; Herbrecht R
    Anticancer Res; 2010 Mar; 30(3):963-5. PubMed ID: 20393020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose methotrexate-doxycycline interaction.
    Tortajada-Ituren JJ; Ordovás-Baines JP; Llopis-Salvia P; Jiménez-Torres NV
    Ann Pharmacother; 1999; 33(7-8):804-8. PubMed ID: 10466909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination.
    Bain E; Birhiray RE; Reeves DJ
    Ann Pharmacother; 2014 Feb; 48(2):292-6. PubMed ID: 24259648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure.
    Zoubek A; Zaunschirm HA; Lion T; Fischmeister G; Vollnhofer G; Gadner H; Pillwein K; Schalhorn A; Bode U
    Pediatr Hematol Oncol; 1995; 12(5):471-7. PubMed ID: 8519632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate poisoning with acute hepatorenal dysfunction.
    Goto E; Tomojiri S; Okamoto I; Tanaka K
    J Toxicol Clin Toxicol; 2001; 39(1):101-4. PubMed ID: 11327217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction between high-dose methotrexate and amoxycillin.
    Ronchera CL; Hernández T; Peris JE; Torres F; Granero L; Jiménez NV; Plá JM
    Ther Drug Monit; 1993 Oct; 15(5):375-9. PubMed ID: 8249043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methotrexate-ciprofloxacin interaction: report of two cases of severe intoxication].
    Dalle JH; Auvrignon A; Vassal G; Leverger G; Kalifa C
    Arch Pediatr; 2001 Oct; 8(10):1078-81. PubMed ID: 11683100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment.
    Blum R; Seymour JF; Toner G
    Ann Oncol; 2002 Feb; 13(2):327-30. PubMed ID: 11886013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
    Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF
    Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
    Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between methotrexate and ciprofloxacin.
    Dalle JH; Auvrignon A; Vassal G; Leverger G
    J Pediatr Hematol Oncol; 2002 May; 24(4):321-2. PubMed ID: 11972105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose methotrexate in fibroblastic osteosarcoma.
    Chowbay B; Siong KK
    Ann Pharmacother; 2001 Dec; 35(12):1669. PubMed ID: 11793640
    [No Abstract]   [Full Text] [Related]  

  • 17. Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma.
    Rousseau A; Sabot C; Delepine N; Delepine G; Debord J; Lachâtre G; Marquet P
    Clin Pharmacokinet; 2002; 41(13):1095-104. PubMed ID: 12403645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible Impaired Methotrexate Clearance After Platinum-Based Chemotherapy for Osteosarcoma.
    Oude Munnink T; van der Meer A; de Haan J; Touw D; van Kruchten M
    Ther Drug Monit; 2019 Dec; 41(6):693-695. PubMed ID: 31169759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
    Estève MA; Devictor-Pierre B; Galy G; André N; Coze C; Lacarelle B; Bernard JL; Monjanel-Mouterde S
    Eur J Clin Pharmacol; 2007 Jan; 63(1):39-42. PubMed ID: 17115148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.